Waiting
Processando Login

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Métodos in vitro para comparar la unión de diana…
JoVE Journal
Immunology and Infection

É necessário ter uma assinatura JoVE para assistir este Faça login ou comece sua avaliação gratuita.

JoVE Journal Immunology and Infection
Métodos in vitro para comparar la unión de diana y la inducción de CDC entre anticuerpos terapéuticos
 
Click here for the English version

Métodos in vitro para comparar la unión de diana y la inducción de CDC entre anticuerpos terapéuticos: Aplicaciones en análisis de biosimilitud

Article DOI: 10.3791/55542-v • 07:25 min • May 4th, 2017
May 4th, 2017 •
1,2, 1, 3, 4,5, 6
1Unit for Development and Research in Bioprocesses Unit (UDIBI), National School of Biological Sciences, National Polytechnic Institute (IPN), University of Mexico (UNAM), 2School of Chemistry, National Autonomous University of Mexico (UNAM), 3Graduate Program in Chemical Sciences, National Autonomous University of Mexico (UNAM), 4Unit for Development Research and Medical Innovation in Biotechnology (UDIMEB), National School of Biological Sciences, National Polytechnic Institute (IPN), 5Department of Immunology, National Scool of Biological Sciences, National Polytechnic Institute (IPN), 6Department of Pharmacology and Unit of Translational Biomedicine (CMN 20 de noviembre), School of Medicine, National Autonomous University of Mexico (UNAM)

Capítulos

Resumo
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Este protocolo describe la comparación in vitro de dos características funcionales clave del rituximab: la unión al diana y la inducción de la citotoxicidad dependiente del complemento (CDC). Los métodos se emplearon para una comparación lado a lado entre el rituximab de referencia y un biosimilar de rituximab. Estos ensayos se pueden emplear durante el desarrollo biosimilar o como un control de calidad en su producción.

Tags

Inmunología No. 123 Rituximab biosimilar anti-CD20 mAb terapéutico CDC citometría de flujo células Daudi
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter